We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TCRT market cap is 22.3M. The company's latest EPS is USD -2.1905 and P/E is -0.61.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.91M | 11k | 0 | 249k | 0 |
| Operating Income | -8.26M | -8.52M | -9.67M | -7.98M | -8.67M |
| Net Income | -8.85M | -9.16M | -10.05M | -8.77M | -8.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 398k | 2.92M | 303k |
| Operating Income | -57.86M | -80.36M | -78.75M | -35.24M | -34.27M |
| Net Income | -117.8M | -79.98M | -78.75M | -37.73M | -35.14M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 67.34M | 64.94M | 48.64M | 27.93M | 19.44M |
| Total Liabilities | 35.23M | 26.38M | 19.13M | 6.28M | 5.54M |
| Total Equity | 32.11M | 38.56M | 29.51M | 21.65M | 13.9M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 109.11M | 146.35M | 94.87M | 64.94M | 8.26M |
| Total Liabilities | 14.1M | 22.36M | 36.81M | 26.38M | 1.96M |
| Total Equity | 95.01M | 123.98M | 58.06M | 38.56M | 6.31M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.1M | -29.23M | -9.38M | -16.38M | -22.76M |
| Investing | -100k | -193k | -23k | -158k | -157k |
| Financing | -2.11M | 6.37M | -6.16M | -18.14M | -18.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.85M | -57.01M | -61.47M | -29.23M | -30.14M |
| Investing | -284k | -9.78M | -3.32M | -193k | 1.35M |
| Financing | 59.15M | 102.12M | 25.78M | 6.37M | -18.14M |
| Market Cap | 22.3M |
| Price to Earnings Ratio | -0.61 |
| Price to Sales Ratio | 70.37 |
| Price to Cash Ratio | 3.52 |
| Price to Book Ratio | 3.38 |
| Dividend Yield | - |
| Shares Outstanding | 16.04M |
| Average Volume (1 week) | 34.83k |
| Average Volume (1 Month) | 51.46k |
| 52 Week Change | -81.13% |
| 52 Week High | 10.47 |
| 52 Week Low | 0.66 |
| Spread (Intraday) | 4.77 (79.5%) |
| Company Name | Alaunos Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.ziopharm.com |
| Industry | spec outpatient facility,nec (8093) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
